Figure 1 where larger RRs indicate that the new drug is associated with a higher rate of the adverse outcome of interest versus the comparator. The dashed vertical line represents
the hypothetical safety threshold (Δ). We describe approachesto developing this threshold below. The solid vertical line represents the null threshold (RR=1), and the horizontal lines represent the CIs.